EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines

Oliver Distler iD, Diana Bonderman, J Gerry Coghlan, Christopher P Denton iD, Ekkehard Grünig, Dinesh Khanna iD, Vallerie V McLaughlin, Ulf Müller-Ladner, Janet E Pope iD, Madelon C Vonk iD, Lilla Di Scala, Jean-Christophe Lemarie und 2 weitere

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42791 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Oliver Distler und 13 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Algorithms, Scleroderma, Systemic, Pulmonary Arterial Hypertension, Hemodynamics. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, Allschwil, Switzerland, Actelion Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The evidence‐based DETECT pulmonary arterial hypertension (PAH) algorithm is frequently used in patients with systemic sclerosis (SSc) to help clinicians screen for PAH by using noninvasive data to recommend patient referral to echocardiography and, if applicable, for a diagnostic right‐sided heart catheterization. However, the hemodynamic definition of PAH was recently updated in the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines. The performance of DETECT PAH in identifying patients with a high risk of PAH according to this new definition was assessed.

Methods

In this post hoc analysis of DETECT, which comprised 466 patients with SSc, the performance of the DETECT PAH algorithm in identifying patients with a high risk of PAH as defined in the 2022 ESC/ERS guidelines (mean pulmonary arterial pressure [mPAP] >20 mm Hg, pulmonary capillary wedge pressure [PCWP] ≤15 mm Hg, and pulmonary vascular resistance >2 Wood units) was assessed using summary statistics and was descriptively compared to the known performance of DETECT PAH as defined in 2014, when it was developed (mPAP ≥25 mm Hg and PCWP ≤15 mm Hg).

Results

The sensitivity of DETECT PAH in identifying patients with a high risk of PAH according to the 2022 ESC/ERS definition was lower (88.2%) compared to the 2014 definition (95.8%). Specificity improved from 47.8% to 50.8%.

Conclusion

The performance of the DETECT algorithm to screen for PAH in patients with SSc is maintained when PAH is defined according to the 2022 ESC/ERS hemodynamic definition, indicating that DETECT remains applicable to screen for PAH in patients with SSc. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsScleroderma, SystemicPulmonary Arterial HypertensionHemodynamicsPractice Guidelines as TopicHumansFemaleMaleMiddle AgedEuropeCardiac CatheterizationAgedSocieties, MedicalHypertension, PulmonarySensitivity and SpecificityVascular ResistanceCardiologyPulmonary Wedge PressureEchocardiography

Autor:innen und Institutionen

  • University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Medical University of Vienna, Vienna, Austria.
  • Royal Free Hospital, London, United Kingdom.
  • Heidelberg University Hospital and Deutsches Zentrum für Lungenforschung, Heidelberg, Germany.
  • University of Michigan, Ann Arbor.
  • Justus-Liebig-University Giessen, Campus Kerckhoff, Bad Nauheim, Germany.

ORCID-Profile: Oliver Distler, Christopher P Denton, Dinesh Khanna, Janet E Pope, Madelon C Vonk

Förderung

  • Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, Allschwil, Switzerland
  • Actelion Pharmaceuticals

Zitieren

APA

Distler, O., Bonderman, D., Coghlan, J. G., Denton, C. P., Grünig, E., Khanna, D., McLaughlin, V. V., Müller-Ladner, U., Pope, J. E., Vonk, M. C., Di Scala, L., Lemarie, J. C., Perchenet, L., & Hachulla, É. (2024). Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines. Arthritis & Rheumatology. https://doi.org/10.1002/art.42791

Vancouver

Distler O, Bonderman D, Coghlan JG, Denton CP, Grünig E, Khanna D, et al. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines. Arthritis & Rheumatology. 2024. doi:10.1002/art.42791

BibTeX
@article{Distler2024,
  author = {Distler, Oliver and Bonderman, Diana and Coghlan, J Gerry and Denton, Christopher P and Grünig, Ekkehard and Khanna, Dinesh and McLaughlin, Vallerie V and Müller-Ladner, Ulf and Pope, Janet E and Vonk, Madelon C and Di Scala, Lilla and Lemarie, Jean-Christophe and Perchenet, Loïc and Hachulla, Éric},
  title = {Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42791}
}
Kostenlos starten →